44 / 114
44
Bibliografia
1. (CDC), C f D C (1981). Kaposi’s sarcoma and Pneumocystis pneumonia
among homosexual men--New York City and California. MMWR Morb Mortal
Wkly Rep 30, 305-308.
2. Barre-Sinoussi, F, Chermann, JC, Rey, F, Nugeyre, MT, Chamaret, S, Gruest,
J, Dauguet, C, Axler-Blin, C, Vezinet-Brun, F, Rouzioux, C, Rozenbaum,W, and
Montagnier, L (1983). Isolation of a T-lymphotropic retrovirus from a patient at
risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
3. Gallo, RC, Salahuddin, SZ, Popovic, M, Shearer, GM, Kaplan, M, Haynes, BF,
Palker,TJ, Redfield, R, Oleske, J, Safai, B, and et al. (1984). Frequent detection and
isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk
for AIDS. Science 224, 500-503.
4. Merson, MH, O’Malley, J, Serwadda, D, and Apisuk, C (2008). The history
and challenge of HIV prevention. Lancet 372, 475-488.
5. Clavel, F, Guetard, D, Brun-Vezinet, F, Chamaret, S, Rey, MA, Santos-Fer-
reira, MO, Laurent, AG, Dauguet, C, Katlama, C, Rouzioux, C, and et al. (1986).
Isolation of a new human retrovirus fromWest African patients with AIDS. Science
233, 343-346.
6. Clavel, F, Mansinho, K, Chamaret, S, Guetard, D, Favier, V, Nina, J, Santos-
-Ferreira, MO, Champalimaud, JL, and Montagnier, L (1987). Human immuno-
deficiency virus type 2 infection associated with AIDS in West Africa. The New
England journal of medicine 316, 1180-1185.
7. Faria, NR, Rambaut,A, Suchard, MA, Baele, G, Bedford,T,Ward, MJ,Tatem,
AJ, Sousa, JD, Arinaminpathy, N, Pepin, J, Posada, D, Peeters, M, Pybus, OG, and
Lemey, P (2014). HIV epidemiology. The early spread and epidemic ignition of
HIV-1 in human populations. Science 346, 56-61.
8. Santiago, M L, Range, F, Keele, B F, Li,Y, Bailes, E, Bibollet-Ruche, F, Fru-
teau, C, Noe, R, Peeters, M, Brookfield, JF, Shaw, GM, Sharp, PM, and Hahn, BH
(2005). Simian immunodeficiency virus infection in free-ranging sooty mangabeys
(Cercocebus atys atys) from theTai Forest, Cote d’Ivoire: implications for the ori-
gin of epidemic human immunodeficiency virus type 2. Journal of virology 79,
12515-12527.
9. Gomes, P, Abecasis, A, Almeida, M, Camacho, R, and Mansinho, K (2003).
Transmission of HIV-2.The Lancet. Infectious diseases 3, 683-684.
10. Robertson, DL,Anderson, JP, Bradac, JA, Carr, JK, Foley, B, Funkhouser, RK,
Gao, F, Hahn, BH, Kalish, ML, Kuiken, C, Learn, GH, Leitner,T, McCutchan, F,
Osmanov, S, Peeters, M, Pieniazek, D, Salminen, M, Sharp, PM,Wolinsky, S, and
Korber, B (2000). HIV-1 nomenclature proposal. Science 288, 55-56.
11. Rambaut, A, Posada, D, Crandall, KA, and Holmes, EC (2004). The causes
and consequences of HIV evolution. Nature reviews. Genetics 5, 52-61.
12. Gilbert, MT, Rambaut,A,Wlasiuk, G, Spira,TJ, Pitchenik,AE, andWorobey,
M (2007).The emergence of HIV/AIDS in the Americas and beyond. Proceedings
of the National Academy of Sciences of the United States of America 104, 18566-
18570.
13. Tristem, M, Mansinho, K, Champalimaud, JL,Ayres, L, and Karpas,A (1989).
Six new isolates of human immunodeficiency virus type 2 (HIV-2) and the molecu-
lar characterization of one (HIV-2CAM2).The Journal of general virology 70 ( Pt
2), 479-484.
14. Piedade, J,Venenno,T, Prieto, E,Albuquerque, R, Esteves,A, Parreira, R, and
Canas-Ferreira,WF (2000). Longstanding presence of HIV-2 infection in Guinea-
-Bissau (West Africa).Acta tropica 76, 119-124.
15. Parreira, R, Piedade, J, Domingues,A, Lobao, D, Santos, M,Venenno,T, Bap-
tista, JL, Mussa, SA, Barreto,AT, Baptista,AJ, and Esteves,A. (2006). Genetic cha-
racterization of human immunodeficiency virus type 1 from Beira, Mozambique.
Microbes and infection / Institut Pasteur 8, 2442-2451.
16. Esteves,A, Parreira, R,Venenno,T, Franco, M, Piedade, J, Germano De Sou-
sa, J, and Canas-Ferreira,W. F. (2002). Molecular epidemiology of HIV type 1 in-
fection in Portugal: high prevalence of non-B subtypes. AIDS research and human
retroviruses 18, 313-325.
17. Abecasis, A, Paraskevis, D, Epalanga, M, Fonseca, M, Burity, F, Bartolomeu,
J, Carvalho, AP, Gomes, P,Vandamme, AM, and Camacho, R (2005). HIV-1 gene-
tic variants circulation in the North of Angola. Infection, genetics and evolution :
journal of molecular epidemiology and evolutionary genetics in infectious diseases
5, 231-237.
18. Abecasis, AB,Wensing, AM, Paraskevis, D,Vercauteren, J,Theys, K,Van de Vi-
jver, DA,Albert, J,Asjo, B, Balotta, C, Beshkov, D, Camacho, RJ, Clotet, B, De Gas-
cun, C, Griskevicius,A, Grossman, Z, Hamouda, O, Horban,A, Kolupajeva,T, Korn,
K, Kostrikis, LG, Kucherer, C, Liitsola, K, Linka, M, Nielsen, C, Otelea, D, Pare-
des, R, Poljak, M, Puchhammer-Stockl, E, Schmit, JC, Sonnerborg,A, Stanekova, D,
Stanojevic, M, Struck, D, Boucher, CA, andVandamme, AM (2013). HIV-1 subtype
distribution and its demographic determinants in newly diagnosed patients in Europe
suggest highly compartmentalized epidemics. Retrovirology 10, 7.
19. Palma, AC, Araújo, F, Duque, V, Borges, F, Paixão, MT, Camacho, R, and
Network, PS (2007). Molecular epidemiology and prevalence of drug resistance-
-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect Genet
Evol 7, 391-398.
20. Bártolo, I, Abecasis, AB, Borrego, P, Barroso, H, McCutchan, F, Gomes, P,
Camacho, R, and Taveira, N (2011). Origin and epidemiological history of HIV-1
CRF14_BG. PLoS One 6, e24130.
21. Esteves,A, Parreira, R, Piedade, J,Venenno,T, Franco, M, Germano de Sousa,
J, Patricio, L, Brum, P, Costa,A, and Canas-Ferreira,WF (2003). Spreading of HIV-
1 subtype G and envB/gagG recombinant strains among injecting drug users in
Lisbon, Portugal.AIDS research and human retroviruses 19, 511-517.
22. Freitas, FB, Esteves,A, Piedade, J, and Parreira, R (2013). Novel multiregion
hybridization assay for the identification of the most prevalent genetic forms of the
human immunodeficiency virus type 1 circulating in Portugal. AIDS research and
human retroviruses 29, 318-328.
23. Chaisson, RE, Allain, JP, Leuther, M, and Volberding, PA (1986). Significant
changes in HIV antigen level in the serum of patients treated with azidothymidine.
The New England journal of medicine 315, 1610-1611.
24. Larder, BA, Darby, G, and Richman, DD (1989). HIV with reduced sensitivity
to zidovudine (AZT) isolated during prolonged therapy. Science 243, 1731-1734.
25. Abecasis, AB,Vandamme, AM, and Lemey, P (2009). Quantifying differences
in the tempo of human immunodeficiency virus type 1 subtype evolution. Journal
of virology 83, 12917-12924.
26. Abecasis,AB, Deforche, K, Snoeck, J, Bacheler, LT, McKenna, P, Carvalho,AP,
Gomes, P, Camacho, RJ, andVandamme,AM (2005). Protease mutation M89I/V is
linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or
G.Aids 19, 1799-1806.
27. Camacho, RJ (2012). Special aspects of the treatment of HIV-2-infected pa-
tients. Intervirology 55, 179-183.
28. Witvrouw, M, Pannecouque, C, Switzer,WM, Folks,TM, De Clercq, E, and
Heneine,W (2004). Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1
compounds: implications for treatment and postexposure prophylaxis. Antiviral
therapy 9, 57-65.
29. Cavaco-Silva, J, Abecasis, A, Miranda, AC, Poças, J, Narciso, J, Águas, MJ,
Maltez, F, Almeida, I, Germano, I, Diniz, A, Gonçalves, M e F, Gomes, P, Cunha,
C, Camacho, RJ, and Group, P. H.-R. S. (2014). HIV-2 integrase polymorphisms
and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-
-containing regimen. PLoS One 9, e92747.
30. Cavaco-Silva, J, Aleixo, MJ,Van Laethem, K, Faria, D,Valadas, E, Gonçalves,
M e. F, Gomes, P,Vandamme,AM, Cunha, C, Camacho, RJ, and Group, P. H.-R. S.
(2013). Mutations selected in HIV-2-infected patients failing a regimen including
atazanavir. J Antimicrob Chemother 68, 190-192.
31. Hamers, FF, and Downs, AM (2004).The changing face of the HIV epidemic
in western Europe: what are the implications for public health policies? Lancet 364,
83-94.
32. Baral, S, Sifakis, F, Cleghorn, F, and Beyrer, C (2007). Elevated risk for HIV
infection among men who have sex with men in low- and middle-income countries
2000-2006: a systematic review. PLoS medicine 4, e339.
33. van de Laar, MJ (2009). HIV/AIDS and other STI in men who have sex with
men--a continuous challenge for public health. Euro surveillance, vol. 14.
34. Boily, MC, Godin, G, Hogben, M, Sherr, L, and Bastos, FI (2005).The impact
of the transmission dynamics of the HIV/AIDS epidemic on sexual behaviour: a
new hypothesis to explain recent increases in risk taking-behaviour among men
who have sex with men. Medical hypotheses 65, 215-226.
35. Beyrer, C, Baral, SD, van Griensven, F, Goodreau, SM, Chariyalertsak, S,
Wirtz, AL, and Brookmeyer, R (2012). Global epidemiology of HIV infection in
men who have sex with men. Lancet 380, 367-377.
36. Grov, C, Hirshfield, S, Remien, RH, Humberstone, M, and Chiasson, MA
(2013). Exploring the venue’s role in risky sexual behavior among gay and bisexual
men: an event-level analysis from a national online survey in the U.S. Archives of
sexual behavior 42, 291-302.
37. Baral, S, Beyrer, C, Muessig, K, Poteat,T,Wirtz, AL, Decker, MR, Sherman,
SG, and Kerrigan, D (2012). Burden of HIV among female sex workers in low-
-income and middle-income countries: a systematic review and meta-analysis.The
Lancet. Infectious diseases 12, 538-549.
38. Dias, S, Gama, A, Fuertes, R, Mendao, L, and Barros, H (2014). Risk-taking
behaviours and HIV infection among sex workers in Portugal: results from a cross-
-sectional survey. Sexually transmitted infections.
39. Dias, S (2015). The role of men who pay for sex in STI transmission: current
knowledge and future directions.The contribution of the third UK National Survey of
SexualAttitudes and Lifestyles (Natsal-3). Sexually transmitted infections 91, 78-79.
40. Dias, S, Gama, A, Severo, M, and Barros, H (2011). Factors associated with
HIV testing among immigrants in Portugal. International journal of public health
56, 559-566.
41. Magnani, R, Sabin, K, Saidel,T, and Heckathorn, D (2005). Review of sam-
pling hard-to-reach and hidden populations for HIV surveillance. Aids 19 Suppl 2,
S67-72.
42. Muhib, FB, Lin, LS, Stueve,A, Miller, RL, Ford,WL, Johnson,WD, Smith, PJ,
andTeam, C. I.T. f.Y. S. (2001).A venue-based method for sampling hard-to-reach
populations. Public Health Rep 116 Suppl 1, 216-222.
43. Israel, BA, Schulz, AJ, Parker, EA, and Becker, AB (1998). Review of com-
munity-based research: assessing partnership approaches to improve public health.
Annual review of public health 19, 173-202.
44. Dias, S, and Gama, A (2014). [Community-based participatory research in
public health: potentials and challenges]. Revista panamericana de salud publica =
Pan American journal of public health 35, 150-154.
Artigo Original